-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SiIg3Uq3b8iXpgHDpPxDElI5GwXGwAVuJBfivif6FIOYUh6YveNATz7ezIuvD4f1 KygcwXBwKbVCK740DC72+Q== 0001179110-07-006036.txt : 20070314 0001179110-07-006036.hdr.sgml : 20070314 20070314164145 ACCESSION NUMBER: 0001179110-07-006036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070313 FILED AS OF DATE: 20070314 DATE AS OF CHANGE: 20070314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 07694033 BUSINESS ADDRESS: BUSINESS PHONE: 650-574-3000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 4 1 edgar.xml FORM 4 - X0202 4 2007-03-13 0 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 0 0 President and CEO Common Stock 2007-03-13 4 M 0 35000 2.8594 A 772629 D Common Stock 2007-03-13 4 S 0 5500 70.105 D 767129 D Common Stock 2007-03-13 4 S 0 10000 70.22 D 757129 D Common Stock 2007-03-13 4 S 0 1500 70.30 D 755629 D Common Stock 2007-03-13 4 S 0 5000 70.2027 D 750629 D Common Stock 2007-03-13 4 S 0 5000 70.2745 D 745629 D Common Stock 2007-03-13 4 S 0 8000 70.4376 D 737629 D Non-Qualified Stock Option (right to buy) 2.8594 2007-03-13 4 M 0 35000 0 D 2008-07-22 Common Stock 35000 210392 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on August 29, 2006. The options vested 20% on July 23, 1999, the first anniversary date of the grant. The balance vested 5% every three months thereafter and was fully vested as of July 23, 2003. /s/ John C. Martin 2007-03-13 -----END PRIVACY-ENHANCED MESSAGE-----